FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/29/2024 |
3. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Shares | 94,148(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (Right to Buy) | (2) | 02/18/2030 | Common Shares | 107,981 | 43.94 | D | |
Employee Stock Option (Right to Buy) | (3) | 03/03/2031 | Common Shares | 74,101 | 39.97 | D | |
Employee Stock Option (Right to Buy) | (4) | 01/09/2032 | Common Shares | 62,047 | 52.12 | D |
Explanation of Responses: |
1. Includes (i) 4,737 unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan (the "Plan"), of which 50% will vest on January 10, 2025 and the remaining 50% will vest on January 10, 2026, subject to the reporting person's continued service through each vesting date, (ii) 24,349 shares underlying performance share units (PSUs) granted under the Plan on March 20, 2022, and (iii) 3,335 shares acquired under the Genpact Employee Stock Purchase Plan. The PSU grant was subject to performance conditions which have been satisfied, and each PSU and RSU represents the contingent right to receive one common share. The 2022 PSU grant will vest on January 10, 2025, subject to the reporting person's continued service through such date. |
2. The option vested 50% on February 19, 2023 and the remaining 50% vests on February 19, 2025, subject to the reporting person's continued service through such date. |
3. The option vested 50% on January 10, 2024 and the remaining 50% vests on January 10, 2026, subject to the reporting person's continued service through such date. |
4. The option vests 50% on January 10, 2025 and 50% on January 10, 2027, subject to the reporting person's continued service through each vesting date. |
Remarks: |
Exhibit 24.1 - Power of Attorney |
/s/ Thomas D. Scholtes, as Attorney-in-fact for Riju Vashisht | 03/11/2024 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |